CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development	$ 64,219	$ 38,622
General and administrative	17,190	14,615
Total operating expenses	81,409	53,237
Loss from operations	(81,409)	(53,237)
Other income (expense):
Interest income	5,945	1,830
Other expense:	(1)	(79)
Total other income	5,944	1,751
Net loss before income taxes	(75,465)	(51,486)
Provision for income taxes	56	25
Net loss	(75,521)	(51,511)
Comprehensive loss:
Net loss	(75,521)	(51,511)
Other comprehensive loss:
Unrealized gain (loss) on securities	703	(407)
Comprehensive loss	$ (74,818)	$ (51,918)
Net loss per share, basic	$ (2.87)	$ (2.10)
Net loss per share, diluted	$ (2.87)	$ (2.10)
Weighted-average shares of common stock outstanding, basic	26,331,630	24,472,104
Weighted-average shares of common stock outstanding, diluted	26,331,630	24,472,104